• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
ZHOU Guangyu,WANG Honghong,SU Hua,JIANG Jin.Research progress of intestinal flora to chronic hepatitis B patient[J].Journal Of Pharmaceutical Research,2020,39(8):477-479,490[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2277times   Download 2649次 QR Code for this article
Scan with your phone!
肠道菌群生态对慢性乙型病毒肝炎患者疾病进展影响的研究进展
周光宇1,王宏虹2,苏华3,焦瑾4
Font:Larger+|Default|Smaller-
(1.广西中医药大学附属瑞康医药药学部,广西 南宁 530000;2.柳州市妇幼保健院药学部,广西 柳州 545001;3.广西中医药研究院,广西 南宁 530022;4.山东省妇幼保健院,山东 济南 250014)
摘要:
目的 了解慢性乙型病毒肝炎患者的肠道微生态环境对其原发病的发展进程的影响,为慢乙肝的诊治提供可靠循证依据。方法 通过对国内外近20年来的文献查阅、整理与分析,阐述肠道菌群生态对慢性乙型病毒肝炎患者疾病进展的影响。结果 乙型肝炎患者的肠道菌群结构多样性较正常人明显减少,慢性肝脏疾病也可以加重肠道菌群失调,反之,肠道微生态的紊乱会导致慢乙肝的症状加重或病程延长,两种因素彼此制约,造成不良的因果循环。结论 针对失衡的肠道微生态环境进行研究,通过补充益生菌或移植粪菌改善肠道生态,进而延缓肝病的进展成为新的切入点。
关键词:  肠道菌群  慢性乙型病毒肝炎  患者
DOI:10.13506/j.cnki.jpr.2020.08.010
基金项目:广西自然科学基金(No.2018JJB140051);柳州市科技计划项目(No.2019BJ10603)
Research progress of intestinal flora to chronic hepatitis B patient
ZHOU Guangyu1,WANG Honghong2,SU Hua3,JIANG Jin4
(1.Department of Pharmacy, Ruikang Hospital Affiliated to Guangxi University of Traditional Chinese Medicine,Nanning 530011,China;2.Department of Pharmacy, Liuzhou Maternity and Child Healthcare Hospital,Liuzhou 545001,China;3.Guangxi Institute of Chinese Medicine&Pharmaceutical Science, Nanning 530022,China;4.Shandong Maternal and Child Health Hospital,Jinan 250014,China)
Abstract:
Objective To study the influence of intestinal flora to chronic hepatitis B patient.Methods Through searching, sorting out and analyzing literature review in recent 20 years at home and abroad, the research profile on the influence of intestinal flora to chronic hepatitis B patient were studied.Results Intestinal flora of chronic hepatitis B patient was less than one of normal person. Intestinal flora and disease interact in a very complex way.Conclusion Delaying the progression of liver disease by supplementing with probiotics or by transplanting faecal bacteria should become a new focus.
Key words:  Intestinal flora  Chronic hepatitis B  Patient
Today's Visits:487    Total Visits:2383201
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.